Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Eduardo H. Charreau
Progesterone Receptor Induces ErbB-2 Nuclear Translocation to Promote Breast Cancer Growth via a Novel Transcriptional Effect: ErbB-2 Function as a Coactivator of Stat3
Molecular and Cellular Biology
Cell Biology
Molecular Biology
Activation of Stat3 by Heregulin/ErbB-2 Through the Co-Option of Progesterone Receptor Signaling Drives Breast Cancer Growth
Molecular and Cellular Biology
Cell Biology
Molecular Biology
Related publications
ErbB-2 Nuclear Function in Breast Cancer Growth, Metastasis and Resistance to Therapy
Endocrine-Related Cancer
Cancer Research
Endocrinology
Oncology
Metabolism
Diabetes
The Oncogenic ErbB-2/ErbB-3 Heterodimer Is a Surrogate Receptor of the Epidermal Growth Factor and Betacellulin
Oncogene
Cancer Research
Genetics
Molecular Biology
Genetic Prodrug Activation in erbB-2 Overexpressing Breast Cancer
Breast Cancer Research
Cancer Research
Oncology
Ibrutinib Inhibits ERBB Receptor Tyrosine Kinases and HER2-Amplified Breast Cancer Cell Growth
Molecular Cancer Therapeutics
Cancer Research
Oncology
Selective Formation of ErbB-2/ErbB-3 Heterodimers Depends on the ErbB-3 Affinity of Epidermal Growth Factor-Like Ligands
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Therapy of Advanced Established Murine Breast Cancer With a Recombinant Adenoviral ErbB-2/neu Vaccine
Cancer Research
Cancer Research
Oncology
TReP-132 Is a Novel Progesterone Receptor Coactivator Required for the Inhibition of Breast Cancer Cell Growth and Enhancement of Differentiation by Progesterone
Molecular and Cellular Biology
Cell Biology
Molecular Biology
Cyclin-Dependent Kinase Activity Is Required for Progesterone Receptor Function: Novel Role for Cyclin a/Cdk2 as a Progesterone Receptor Coactivator
Molecular and Cellular Biology
Cell Biology
Molecular Biology
